文献速递儿科与产科急症重症综合管理与镇静镇痛

早产儿输血后组织氧合变化与结局:TOP随机临床试验的近红外光谱二次研究

Tissue Oxygenation Changes After Transfusion and Outcomes in Preterm Infants: A Secondary Near-Infrared Spectroscopy Study of the Transfusion of Prematures Randomized Clinical Trial (TOP NIRS).
PubMed 文献 · JAMA Netw Open · 2023-09-05
一句话结论早产儿输血后脑与肠系膜组织饱和度升高而SpO2无变化,输血前平均脑饱和度低于50%的输血次数与死亡或神经发育损害相关(OR 2.41)。

该研究为TOP多中心随机临床试验的前瞻性观察性二次研究,纳入16个新生儿重症监护病房中胎龄22至28周、出生体重1000 g及以下的早产儿,随机接受较高或较低血红蛋白阈值输血,并进行近红外光谱监测。179名婴儿入组,101名婴儿的237次输血事件获得有效数据。输血后脑饱和度在低阈值组平均升高4.8%(95%CI 2.7%-6.9%),高阈值组升高2.7%(95%CI 1.2%-4.2%);肠系膜饱和度分别升高6.7%(95%CI 2.4%-11.0%)与5.6%(95%CI 2.7%-8.5%);两组脑与肠系膜组织氧摄取分数均相似程度下降;两组SpO2均无显著变化(0.2% vs -0.2%)。36名婴儿(37%)发生神经发育损害或死亡,输血前平均脑饱和度低于50%的输血次数与神经发育损害或死亡相关(OR 2.41;95%CI 1.08-5.41;P=.03)。作者认为输血前较低脑饱和度可能与不良结局相关,支持进一步研究靶向组织饱和度监测。

要点

  • 早产儿输血后脑饱和度平均升高:低血红蛋白阈值组4.8%(95%CI 2.7%-6.9%),高阈值组2.7%(95%CI 1.2%-4.2%)。
  • 输血后肠系膜饱和度平均升高:低阈值组6.7%(95%CI 2.4%-11.0%),高阈值组5.6%(95%CI 2.7%-8.5%)。
  • 输血后两组SpO2均无显著变化(0.2% vs -0.2%),组织饱和度升高不能由SpO2变化解释。
  • 输血前平均脑饱和度低于50%的输血次数与神经发育损害或死亡相关(OR 2.41;95%CI 1.08-5.41;P=.03)。
  • 神经发育损害或死亡发生于36名婴儿(37%),评估时间点为矫正年龄22至26个月。

适用人群与场景

  • 胎龄22至28周、出生体重1000 g或以下的早产儿,来自TOP多中心随机临床试验的婴儿子集。
  • 研究场景为16个新生儿重症监护病房,研究期间为2015年8月至2017年4月。

诊断标准与关键阈值

  • 神经发育损害定义:认知延迟(贝利婴幼儿发展量表第三版评分<85)、粗大运动功能分类系统II级或以上的脑性瘫痪、或严重视力或听力损害。
  • 输血前平均脑饱和度低于50%作为与结局相关的阈值。

研究设计与关键结果

  • 研究类型:前瞻性观察性二次研究,嵌套于TOP多中心随机临床试验,16个新生儿重症监护病房,179名婴儿入组(45名[44.6%]男性),平均(SD)胎龄25.9(1.5)周,101名婴儿的237次输血事件获得有效数据。
  • 输血后脑饱和度平均升高:低血红蛋白阈值组4.8%(95%CI 2.7%-6.9%)vs 高血红蛋白阈值组2.7%(95%CI 1.2%-4.2%)。
  • 输血后肠系膜饱和度平均升高:低阈值组6.7%(95%CI 2.4%-11.0%)vs 高阈值组5.6%(95%CI 2.7%-8.5%)。
  • 脑与肠系膜组织氧摄取分数在两组均相似程度下降。
  • SpO2在两组均无显著变化(0.2% vs -0.2%)。
  • 神经发育损害或死亡发生于36名婴儿(37%);输血前平均脑饱和度低于50%的输血次数与神经发育损害或死亡相关(OR 2.41;95%CI 1.08-5.41;P=.03)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性二次研究,数据来自TOP多中心随机临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为输血前较低脑饱和度可能与不良结局相关,支持进一步研究早产贫血儿靶向组织饱和度监测。

指南或共识出处

  • Transfusion of Prematures (TOP) randomized clinical trial(ClinicalTrials.gov Identifier: NCT01702805)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Preterm infants with varying degrees of anemia have different tissue oxygen saturation responses to red blood cell (RBC) transfusion, and low cerebral saturation may be associated with adverse outcomes.

OBJECTIVE: To determine whether RBC transfusion in preterm infants is associated with increases in cerebral and mesenteric tissue saturation (Csat and Msat, respectively) or decreases in cerebral and mesenteric fractional tissue oxygen extraction (cFTOE and mFTOE, respectively) and whether associations vary based on degree of anemia, and to investigate the association of Csat with death or neurodevelopmental impairment (NDI) at 22 to 26 months corrected age.

DESIGN, SETTING, AND PARTICIPANTS: This was a prospective observational secondary study conducted among a subset of infants between August 2015 and April 2017 in the Transfusion of Prematures (TOP) multicenter randomized clinical trial at 16 neonatal intensive care units of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Preterm neonates with gestational age 22 to 28 weeks and birth weight 1000 g or less were randomized to higher or lower hemoglobin thresholds for transfusion. Data were analyzed between October 2020 and May 2022.

INTERVENTIONS: Near-infrared spectroscopy monitoring of Csat and Msat.

MAIN OUTCOMES AND MEASURES: Primary outcomes were changes in Csat, Msat, cFTOE, and mFTOE after transfusion between hemoglobin threshold groups, adjusting for age at transfusion, gestational age, birth weight stratum, and center. Secondary outcome at 22 to 26 months was death or NDI defined as cognitive delay (Bayley Scales of Infant and Toddler Development-III score <85), cerebral palsy with Gross Motor Function Classification System level II or greater, or severe vision or hearing impairment.

RESULTS: A total of 179 infants (45 [44.6%] male) with mean (SD) gestational age 25.9 (1.5) weeks were enrolled, and valid data were captured from 101 infants during 237 transfusion events. Transfusion was associated with a significant increase in mean Csat of 4.8% (95% CI, 2.7%-6.9%) in the lower-hemoglobin threshold group compared to 2.7% (95% CI, 1.2%-4.2%) in the higher-hemoglobin threshold group, while mean Msat increased 6.7% (95% CI, 2.4%-11.0%) vs 5.6% (95% CI, 2.7%-8.5%). Mean cFTOE and mFTOE decreased in both groups to a similar extent. There was no significant change in peripheral oxygen saturation (SpO2) in either group (0.2% vs -0.2%). NDI or death occurred in 36 infants (37%). Number of transfusions with mean pretransfusion Csat less than 50% was associated with NDI or death (odds ratio, 2.41; 95% CI, 1.08-5.41; P = .03).

CONCLUSIONS AND RELEVANCE: In this secondary study of the TOP randomized clinical trial, Csat and Msat were increased after transfusion despite no change in SpO2. Lower pretransfusion Csat may be associated with adverse outcomes, supporting further investigation of targeted tissue saturation monitoring in preterm infants with anemia.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01702805.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Chock VY, Kirpalani H, Bell EF, et al. Tissue Oxygenation Changes After Transfusion and Outcomes in Preterm Infants: A Secondary Near-Infrared Spectroscopy Study of the Transfusion of Prematures Randomized Clinical Trial (TOP NIRS). JAMA Netw Open. 2023. PMID: 37733345. doi:10.1001/jamanetworkopen.2023.34889

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。